Navigation Links
Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash
Date:3/29/2011

on.  ALL INVESTORS AND SECURITY HOLDERS OF CEPHALON ARE URGED TO READ ANY SUCH DOCUMENTS FILED WITH THE SEC BY VALEANT CAREFULLY AND IN THEIR ENTIRETY, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT ANY SUCH TRANSACTION.  Investors and security holders will be able to obtain free copies of documents filed with the SEC by Valeant (when they become available) at the web site maintained by the SEC at www.sec.gov or from Valeant's website (www.valeant.com) under the tab "Investor Relations" and then under the heading "SEC Filings," or by directing a request to Valeant, One Enterprise, Aliso Viejo, California, 92656, Attention: Corporate Secretary.  

CERTAIN INFORMATION CONCERNING POTENTIAL PARTICIPANTS IN A SOLICITATION

Valeant, Mr. J. Michael Pearson, Ms. Laurie W. Little and certain of the other directors, executive officers and employees of Valeant may be deemed to be participants in a solicitation under the rules of the SEC.  If any consent solicitation is commenced by Valeant in respect of the election of directors to the Board of Directors of Cephalon, the persons nominated by Valeant for election to the Board of Directors may also be deemed to be participants in such solicitation.

Mr. J. Michael Pearson is the Chairman and Chief Executive Officer of Valeant.

Ms. Laurie W. Little is Vice President, Investor Relations of Valeant.

The principal business address of each of Mr. Pearson and Ms. Little is 14 Main St # 140, Madison, New Jersey 07940-1818.

As of the date hereof, Valeant may be deemed to be the beneficial owner of 1,034,908 shares of the common stock of Cephalon, par value $0.01 per share ("Common Stock"), representing 1.366% of the shares of Common Stock outstanding as of March 14, 2011, according to Cephalon's filing on Schedule 14A on March 25, 2011.  In addition, as of the date hereof, Valeant may
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Valeant to Acquire Polish Products
2. GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
3. Valeant and Biovail Announce Results of Special Meetings of Shareholders
4. Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016
5. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
6. Valeant Pharmaceuticals Reports 2010 Third Quarter Financial Results
7. Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan
8. Valeant Announces Pricing of Senior Notes
9. Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
10. Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO
11. Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 31, 2014 Touro University California,s College of ... as the recipient of a $150,000 grant by the ... University to increase research and classroom space on its ... for the study of health sciences, and will help ... and interests of our students," said Shelley Berkley ...
(Date:7/31/2014)... Colo. , July 31, 2014  Cannabis ... in cannabis formulation-based drug development and related consulting, ... production of multiple strains of cannabis and European ... to select the best strains for development of ... the cannabis formulations to market for critical ailments ...
(Date:7/31/2014)... Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company ... conference call on Thursday, August 14, 2014, at 4:30 p.m. ... June 30, 2014. Financial results will be issued in a ... President and CEO James LaFrance will host the ... Date: Thursday, August 14, 2014 Time: 4:30 p.m. Eastern time ...
Breaking Medicine Technology:Touro University California Garners Grant From Long Foundation 2Cannabis Science Initiates Scientific Cultivation Programs to Test Multiple Strains of Cannabis to Obtain Extract Formulations for Clinical Drug Development Targeting Multiple Critical Ailments Starting with Cancer and Neurological Disorders 2Vermillion Sets Second Quarter 2014 Conference Call for Thursday, August 14, 2014 2
...  Eli Lilly and Company (NYSE: LLY ) has ... Women" list for the fourth consecutive year. ... Executives (NAFE), recognizes U.S. companies whose policies and practices encourage ... leadership, demonstrate that commitment. The NAFE Top Companies ...
... NEW YORK, Feb. 6, 2012 Faruqi & ... is investigating potential securities fraud at GenVec, Inc. ... (Logo:  http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) ... its executives violated federal securities laws by failing ...
Cached Medicine Technology:Lilly Recognized as a Top Company for Executive Women 2Faruqi & Faruqi, LLP Announces Investigation of GenVec, Inc. 2
(Date:7/31/2014)... Fitness on the Go in-home ... which now includes Ottawa along with all major cities ... fitness to clients in Ontario since 2012, but have ... a Canadian owned in-home fitness and personal training company ... and fitter lifestyle. , Fitness on the Go makes ...
(Date:7/31/2014)... Atlanta-based Jvion, a leader in clinical ... lessons in predictive population health analytics as part of ... analytics in healthcare. Ritesh Sharma, Jvion COO, commented, “it ... to understand the impact of and potential within predictive ... and a good portion of it is conflicting or ...
(Date:7/31/2014)... Morristown, NJ (PRWEB) July 31, 2014 ANS ... they receive about the ANS Skull Base Center and what ... the ANS Skull Base Surgery Center ?, Skull base ... reaches the undersurface of the brain, an area historically considered ... way to access these areas was by retracting healthy brain ...
(Date:7/31/2014)... During the July 2014 board meeting of the ... executive director of the Mesothelioma Applied Research Foundation, Mary ... promising clinical trials to choose from than ever before. ... have been reporting increased survival and response rates. Some ... is within the field of immunotherapy. One trial, ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 ProPilates ... with a comprehensive approach to the entire body by ... Pilates studio in South Florida with expectations of continual ... , “We are honored to be a part of ... are proactively seeking a way to improve their health ...
Breaking Medicine News(10 mins):Health News:Fitness on the Go Grows to Ottawa 2Health News:Jvion Releases Top Three Lessons in Predictive Population Health Analytics 2Health News:Jvion Releases Top Three Lessons in Predictive Population Health Analytics 3Health News:Dr. Yaron Moshel of Atlantic NeuroSurgical Specialists (ANS) Discusses Brain Tumor Surgery 2Health News:Dr. Yaron Moshel of Atlantic NeuroSurgical Specialists (ANS) Discusses Brain Tumor Surgery 3Health News:‘More Promising Mesothelioma Clinical Trials than Ever Before,’ Says Expert 2Health News:‘More Promising Mesothelioma Clinical Trials than Ever Before,’ Says Expert 3Health News:Fort Lauderdale Pilates Studio ProPilates Reaches Record Growth with Launch of Spinlates by Pilates Powerhouse and Studio Owner, Tonka Cascais 2Health News:Fort Lauderdale Pilates Studio ProPilates Reaches Record Growth with Launch of Spinlates by Pilates Powerhouse and Studio Owner, Tonka Cascais 3
... , , PITTSBURGH , Jan. 14 ... union, today said that the union is pleased with the progress ... for working families. , (Logo: http://www.newscom.com/cgi-bin/prnh/20080131/DC12982LOGO ) , ... for generations we,ve been fighting for health care for all in ...
... , Jan. 14 Today, attorneys with ... a class action law suit and preliminary injunction on ... Angeles Regional Center (ELARC) for unlawfully terminating the most ... through which the state provides statutorily-required services to people ...
... WASHINGTON , Jan. 14 For those who may ... dealing with the images of the Haiti earthquake aftermath, ... from afar and tips for recovering from disasters on its Web ... lives, the wounded and the destruction of homes and communities as ...
... Jan. 14 As the House and Senate work ... Liability and Access (HCLA) sent a letter to House Speaker ... emphasizing the need to retain and strengthen current medical liability reform ... climate has prevented comprehensive medical liability reform efforts from passing, we ...
... , Jan. 14 Resident Sabrina Ahmed ... slowly to get anything done in her home. To make things easier ... wheelchair through her insurance coverage. Unfortunately, the chair didn,t work, and she ... to call " 7 On Your Side " news (WSPA-TV). WSPA Anchor ...
... may be unfounded, agency says , THURSDAY, Jan. 14 ... on Thursday said it found no good evidence that ... use it to help control chronic obstructive pulmonary disease ... early 2008 by the drug,s maker, "suggesting a small ...
Cached Medicine News:Health News:Health Reform Tax Changes: Good Progress for Workers; Union to Keep Working for Better Bill 2Health News:Class Action Suit Filed to Defend Rights of Children With Autism to Vital, Cost-Saving Treatment 2Health News:Class Action Suit Filed to Defend Rights of Children With Autism to Vital, Cost-Saving Treatment 3Health News:APA Offers Resources on Managing Traumatic Stress in Wake of Haiti Earthquake 2Health News:APA Offers Resources on Managing Traumatic Stress in Wake of Haiti Earthquake 3Health News:Broad Health Coalition Continues to Press for Medical Liability Reform 2Health News:The SCOOTER Store Answers Local News Viewer's Need for Power Chair 2Health News:The SCOOTER Store Answers Local News Viewer's Need for Power Chair 3Health News:Leading COPD Drug Won't Harm Heart: FDA 2Health News:Leading COPD Drug Won't Harm Heart: FDA 3Health News:Leading COPD Drug Won't Harm Heart: FDA 4
Adjustable Velcro© closures at crown and behind the neck distinguish this immediate post-op face and chin garment for maximum support and compression....
Facial Wrap...
Very compressive support for submental liposuction...
Ideal for autoplasty and liposuction of chin and cheeks...
Medicine Products: